We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

1,079 hedge funds and large institutions have $56.6B invested in Regeneron Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 175 funds opening new positions, 428 increasing their positions, 321 reducing their positions, and 97 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 175 | Existing positions closed: 97

33% more repeat investments, than reductions

Existing positions increased: 428 | Existing positions reduced: 321

6% more funds holding

Funds holding: 1,017 → 1,079 (+62)

4% more capital invested

Capital invested by funds: $54.4B → $56.6B (+$2.25B)

0.66% less ownership

Funds ownership: 86.01% → 85.34% (-0.66%)

12% less funds holding in top 10

Funds holding in top 10: 17 → 15 (-2)

33% less call options, than puts

Call options by funds: $985M | Put options by funds: $1.48B

Holders
1,079
Holders Change
+62
Holders Change %
+6.1%
% of All Funds
16.61%
Holding in Top 10
15
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-11.76%
% of All Funds
0.23%
New
175
Increased
428
Reduced
321
Closed
97
Calls
$985M
Puts
$1.48B
Net Calls
-$492M
Net Calls Change
-$207M

Top Buyers

1
JP Morgan Chase
JP Morgan Chase
New York
+$301M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$239M
3
Two Sigma Investments
Two Sigma Investments
New York
+$196M
4
Dodge & Cox
Dodge & Cox
California
+$172M
5
BlackRock
BlackRock
New York
+$150M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$618M
2
Capital International Investors
Capital International Investors
California
-$532M
3
AIM
ARK Investment Management
Florida
-$218M
4
Fidelity International
Fidelity International
Bermuda
-$162M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$143M
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
626
Solstein Capital
California
$643K +$596K +969 +1,978%
IB
627
Intrust Bank
Kansas
$641K +$12.3K +20 +2%
TAM
628
Trust Asset Management
Texas
$634K – – –
PAM
629
Paradigm Asset Management
New York
$632K – – –
LOAMS
630
Lombard Odier Asset Management (Switzerland)
Switzerland
$631K +$614K +999 New
CCM
631
CAAS Capital Management
New York
$628K – – –
OPA
632
Old Port Advisors
Maine
$628K – – –
SIM
633
Sentry Investment Management
Wisconsin
$628K – – –
APP
634
Alpha Paradigm Partners
Illinois
$625K +$136K +221 +29%
MA
635
MUFG Americas
New York
$623K -$34.4K -56 -5%
MFG
636
Magnus Financial Group
New York
$622K +$22.7K +37 +4%
XF
637
XML Financial
Maryland
$621K -$12.3K -20 -2%
AII
638
AGF Investments Inc
Ontario, Canada
$620K -$287K -467 -32%
NERM
639
New England Research & Management
Illinois
$616K +$221K +360 +59%
OGC
640
Oak Grove Capital
New Hampshire
$613K -$30.7K -50 -5%
GDP
641
Great Diamond Partners
Maine
$612K +$615 +1 +0.1%
AMR
642
Asset Management Resources
Massachusetts
$611K +$595K +968 New
SIC
643
Samalin Investment Counsel
New York
$606K – – –
MIC
644
Meridian Investment Counsel
California
$605K +$589K +958 New
BWAM
645
Boyd Watterson Asset Management
Ohio
$601K – – –
RCAG
646
Rehmann Capital Advisory Group
Michigan
$601K +$27.1K +44 +5%
OPS
647
Orion Portfolio Solutions
Nebraska
$595K -$234K -381 -29%
SA
648
Sicart Associates
New York
$591K -$78.7K -128 -12%
BPC
649
Banque Pictet & Cie
Switzerland
$586K – – –
PNAA
650
Pictet North America Advisors
Switzerland
$586K – – –
24 25
26
27 28

REGN Hedge Fund Activity: Q4 2021 in Review

1,079 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q4 2021, worth a combined $56.6B — up 4.1% from $54.4B a quarter earlier.

Buyers outnumbered sellers: 175 funds opened new REGN positions and 97 closed out — a net gain of 78 holders — while 428 added to existing stakes and 321 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $301M. The largest seller was Fidelity Investments, cutting an estimated $618M.

  • 1,079 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q4 2021, up from 1,017 in Q3 2021.
  • Funds reported $56.6B of Regeneron Pharmaceuticals stock for Q4 2021, up 4.1% quarter-over-quarter.
  • 175 funds opened new Regeneron Pharmaceuticals positions in Q4 2021 and 97 closed out, a net change of +78 holders.
  • The largest Regeneron Pharmaceuticals buyer in Q4 2021 was JP Morgan Chase, an estimated $301M added.
  • The largest Regeneron Pharmaceuticals seller in Q4 2021 was Fidelity Investments, an estimated $618M sold.

Based on aggregated 13F filings for Q4 2021.